Perella Weinberg May Be 20% Undervalued, but Q2 Earnings Look Like a Bad Bargain

Valuation still leans on recovery, not current earnings power

At $18.02, Perella Weinberg may still sit below fair value, but it is trading at 59.6x P/E. That is rich relative to the earnings base the company is producing today. The multiple only works if investors are comfortable paying in advance for a recovery.

That is the risk after the latest quarter. A standout earnings print can make investors overweight one good report and underwrite a rebound that is still incomplete.

Q2 beat improved sentiment, but it did not normalize the year

On the surface, Q2 looked strong. Revenue came in at $156.5 million, beating estimates by 8.1%, and adjusted EPS of $0.20 compared with $0.06 was even more striking.

But the more measured read is narrower: this was a solid quarter, not clear evidence of full-year normalization. First-half revenue was still down 17% from a year ago, the firm posted a GAAP pre-tax loss of $5 million, and adjusted pre-tax income was $23 million.

So the tension is straightforward. If you are paying for a 2026 recovery, PWP can still make sense. If you are paying for today's earnings power, the stock looks expensive.

The bull case depends on backlog converting into revenue

The bullish argument works because it rests on an operating sequence, not just a one-quarter sentiment swing. Perella Weinberg entered this cycle with $116 million of cash and no debt, giving it flexibility to keep investing rather than simply defend the balance sheet.

Management also said booked revenue plus announced and pending backlog stands well above the level this time last year and that the pace of announced transactions has accelerated. In advisory, that is the setup investors want to believe in: a healthier pipeline can become realized revenue if markets stay even moderately stable.

The latest quarter made that view easier to hold. Revenue of $156.5 million and adjusted EPS of $0.20 came ahead of expectations even though sales were flat year over year. Bulls see timing, not broken demand. Bears see continued softness, reinforced by a 27% quarter over quarter revenue decline and a 43% year-over-year drop from the prior year's record base.

What strengthens the bull case beyond narrative is the capital build. Year to date, the firm added ten partners and eleven managing directors, with more senior hires expected, and it expects to close Gleacher Shacklock in the third quarter. In a boutique model, that is how a better market gets translated back into earning power. The catch is timing: backlog, talent, and acquisitions only matter when they show up in reported revenue and margins.

July 31 is the next proof point

The key question is no longer whether PWP can recover. It is whether the next update narrows the gap between hope and evidence.

The July 31 call shifts the debate

Management is scheduled to speak on the July 31, 2026 at 9:00 AM EDT earnings call. Investors will want signs that backlog is converting into realized revenue, not simply accumulating.

That timing matters because the stock is still around $18.02, while the average analyst target remains near $22.88. The market appears to be pricing in some recovery, but not the full re-rating.

If the company shows real conversion and margin durability, the stock can move higher quickly. If confirmation keeps slipping, valuation compression becomes easier because investors rarely stay patient when execution lags.

Why bulls and bears still have reasonable cases

Bulls have real support for their view. They are leaning on the backlog build, the cash and no debt balance sheet, and the expected close of Gleacher Shacklock in the third quarter. They also have a case that cost discipline and a decreasing share count can help earnings grow faster than revenue.

Bears also have a valid case. One strong quarter does not erase the first-half slowdown, when revenue fell 17% from a year ago and the firm posted a GAAP pre-tax loss. The last time PWP missed on the quarterly print, the market reacted badly to revenue below analyst estimates and EPS missing consensus by $0.02. When investors start fearing another demand reset, they tend to discount backlog much more aggressively.

What to watch next

The stock is not cheap on current earnings power, but it also is not fully priced for a clean recovery. The next update should clarify which bias matters more.

Signs that would strengthen the setup: - clearer linkage between backlog and expected revenue realization - commentary suggesting deal conversion is accelerating, not just pending - tone that cost discipline and share-count support remain intact

Signs that would weaken it: - another quarter of revenue below expectations, as previously seen with revenue below analyst estimates - vaguer timing on when backlog turns into realized revenue - signs that backlog is drifting further out instead of converting